1419 — Human Health Holdings Income Statement
0.000.00%
Last trade - 00:00
- HK$371.96m
- HK$47.78m
- HK$1.00bn
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 529 | 454 | 655 | 1,122 | 1,002 |
Cost of Revenue | |||||
Gross Profit | 248 | 190 | 377 | 660 | 593 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 490 | 487 | 484 | 672 | 753 |
Operating Profit | 38.5 | -33.2 | 171 | 450 | 249 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 34.7 | -39 | 169 | 445 | 239 |
Provision for Income Taxes | |||||
Net Income After Taxes | 26.3 | -40.4 | 144 | 375 | 181 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 26.6 | -40.4 | 144 | 375 | 181 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 26.6 | -40.4 | 144 | 375 | 181 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.072 | -0.112 | 0.338 | 1 | 0.598 |
Dividends per Share |